Table 7. | Characteristics of included study |
| Study | Study design |
Follow-up (month) |
Number of patients |
Age (years) |
Gender | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Test | Control | Test | Control | Test | Control | |||||
| Mean (SD) | Mean (SD) | Male | Female | Male | Female | ||||||
| Eshkol-Yogev et al. [16] |
Randomized controlled trial |
3 | 32 | 17 | 15 |
50 (12.8) (range 28 to 79) |
50 (16) (range 28 to 78) |
7 | 10 | 8 | 7 |
| Li Manni et al. [17] |
Randomized controlled trial |
12 | 34 | 17 | 17 | 46.8 (11.3) | 45.7 (10.4) | 5 | 12 | 5 | 12 |
| Tokuc and Kan [18] |
Randomized controlled trial |
12 | 20 | 20 | 20 | 60.8 (6.4) | 60.8 (6.4) | 8 | 12 | 8 | 12 |
| Hurtgen et al.* [19] |
Randomized controlled trial |
36 | 26 | 13 | 13 | 46.8 (11.3) | 45.7 (10.4) | NR | NR | NR | NR |
|
Randomized controlled trial |
60 | 25 | 11 | 14 | 46.8 (11.3) | 45.7 (10.4) | NR | NR | NR | NR | |
| Tokuc and Kan [20] |
Cohort study |
60 | 19 | 19 | 19 | 64.8 (6.1) | 64.8 (6.1) | 7 | 12 | 7 | 12 |
SD = standard deviation; NR = not recorded; test = MIS® V3; control = MIS® C1.
|
.png)
.png)
.png)
.png)
.png)
.png)
.png)